These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 11727628)
1. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma]. Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628 [TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation]. Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893 [TBL] [Abstract][Full Text] [Related]
3. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy. Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976 [TBL] [Abstract][Full Text] [Related]
4. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506 [TBL] [Abstract][Full Text] [Related]
5. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma. Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734 [TBL] [Abstract][Full Text] [Related]
6. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer. Aras G; Gültekin SS; Küçük NO Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305 [TBL] [Abstract][Full Text] [Related]
7. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients. Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540 [TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin and thyroglobulin autoantibodies measurement using the automated KRYPTOR® platform in patients with differentiated thyroid carcinoma. Giovanella L; Toffalori E; Ceriani L; Caputo M; Verburg FA Horm Metab Res; 2011 Sep; 43(10):728-30. PubMed ID: 21932179 [TBL] [Abstract][Full Text] [Related]
10. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas]. Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345 [TBL] [Abstract][Full Text] [Related]
12. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128 [TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Spencer CA; Wang CC Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of interference of thyroglobulin autoantibodies with assay of thyroglobulin using electrochemiluminescent assay]. Dai Q; Kuang A Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):780-3. PubMed ID: 21936380 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer]. Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046 [TBL] [Abstract][Full Text] [Related]
18. Prevalence, clinical significance and prognostic value of anti-thyroglobulin antibodies in the follow-up of patients with differentiated thyroid carcinoma: a retrospective study. Pedrazzini L; Baroli A; Lomuscio G; Marzoli L Minerva Endocrinol; 2009 Sep; 34(3):195-203. PubMed ID: 19859043 [TBL] [Abstract][Full Text] [Related]
20. [Research on comparison of thyroglobulin autoantibody interference in measurement of thyroglobulin between electrochemiluminescent assay and radioimmunoassay]. Dai Q; Kuang A Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):242-6. PubMed ID: 22616166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]